In 2019 I completed my PhD at the University of Manchester (in collaboration with AstraZeneca). My research focussed on assessing the role of epigenetic factors in chromosome instability following compound exposure. Through my PhD, I developed a keen interest in the effects that pharmaceuticals and environmental compounds have on the DNA methylome and its possible links to classical genotoxic endpoints. Following on from my PhD I became a Research Associate at King’s College London, within the Environmental Carcinogenesis group headed by Professor David Phillips, where I continued along a similar vein of research focussing on establishing DNA mutational signatures of defined mutagens as part of the Mutographs of Cancer – CRUK Grand Challenge Project. As of 2021 I moved into industry taking on a Senior Scientist role in Genetic Toxicology at AstraZeneca where I support early in vitro assessment of genotoxicity. I have been a UKEMS member since 2015 and joined the NUKEMS committee in 2021.